Black Bird Biotech Inc (BBBT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 16, 15:34
Black Bird Biotech Profit Margin (Quarterly): -3.33K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -3.33K% |
June 30, 2023 | -1.52K% |
March 31, 2023 | -3.61K% |
December 31, 2022 | -2.00K% |
September 30, 2022 | -873.4% |
June 30, 2022 | -1.69K% |
March 31, 2022 | -4.86K% |
December 31, 2021 | -3.93K% |
September 30, 2021 | -967.3% |
June 30, 2021 | -805.4% |
March 31, 2021 | -9.44K% |
December 31, 2020 | -23.87K% |
September 30, 2020 | -1.13K% |
June 30, 2020 | -122.1% |
March 31, 2020 | -1.16K% |
December 31, 2019 | 80.87% |
September 30, 2019 | -330.8% |
June 30, 2019 | -1.19K% |
March 31, 2019 | -3.15K% |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | -9.04% |
June 30, 2011 | -60.75% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.87K%
Minimum
Dec 2020
80.87%
Maximum
Dec 2019
-3.38K%
Average
-1.36K%
Median
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -533.7% |
Gross Profit Margin (Quarterly) | 36.02% |
Operating Margin (Quarterly) | -276.5% |
Return on Net Operating Assets | -666.0% |